Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?

González-Padilla, Daniel A; Subiela, José Daniel; Villacampa-Aubá, Felipe.

Afiliação

González-Padilla DA; Department of Urology, Clínica Universidad de Navarra, Madrid, Spain.
Subiela JD; Department or Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain.
Villacampa-Aubá F; Department of Urology, Clínica Universidad de Navarra, Madrid, Spain.

Transl Androl Urol ; 13(4): 639-642, 2024 Apr 30.

Article em En | MEDLINE | ID: mdl-38721284